Eric Linsley
InvestorManaging Partner at BioInnovation Capital · Board director at Cereius · Executive at Envisia Therapeutics
Durham, North Carolina
Writes $100K – $5M checks · typically $1.5M
Find your path to Eric
219 people in our graph share verified history with Eric — schools, employers, funds. One of them is your warm intro.
About
Eric Linsley is Managing General Partner at BioInnovation Capital, where he oversees fund operations, manages the North Carolina laboratory, and invests in therapeutics, laboratory tools, diagnostics, and devices. He previously spent over two decades at Pappas Ventures in Durham, North Carolina, where he sourced and managed investments in numerous life sciences companies, including Peninsula Pharmaceuticals (acquired by Johnson & Johnson), Cerexa (acquired by Forest Laboratories), and public companies such as LipoScience, Liquidia, and Ultragenyx. Prior to Pappas Ventures, he served as Chief Financial Officer of AutoCyte and TriPath Imaging, a medical device company acquired by Becton Dickinson in 2006.
Board director at Cereius
Intro paths
In turn, Eric can intro founders to Cereius's investors below.
Cereius's investors · 1
Executive at Envisia Therapeutics
Intro paths
In turn, Eric can intro founders to Envisia Therapeutics's investors below.
Experience
- BioInnovation CapitalManaging General Partnercurrent2017 — presentRaleigh-Durham, North Carolina Area
- BioLabs North CarolinaCo-Foundercurrent2016 — presentRaleigh-Durham, North Carolina Area
- Envisia TherapeuticsChief Financial Officer2015 — 2017Raleigh-Durham, North Carolina Area
- VariousLife Science Venture Capitalist2000 — 2014Raleigh-Durham, North Carolina Area
- TriPath ImagingCFO, VP Operations1997 — 2000Burlington, NC
- Ampersand VenturesPartner1994 — 1997Wellesley, MA
- Ampersand VenturesAssociate1991 — 1994Wellesley, MA
- Bain & CompanyConsultant1989 — 1991Greater Boston Area
- McKinsey & CompanyConsultant1988Greater New York City Area
- Arthur AndersenCPA1985 — 1987
Skills & more
+12 more
Intellectual PropertyBusiness DevelopmentClinical DevelopmentEntrepreneurshipBiotechnologyTechnology TransferLicensingVenture FinancingStrategic PartnershipsProduct DevelopmentPharmaceutical IndustryHealthcareFrom Eric's professional profile.
Deals · 1
CereiusBoard seat
via BioInnovation Capital · filed Aug 2018 · $6M raise
Attribution from SEC filings, press coverage, and firm rosters.
Network3
Investors connected to Eric in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Eric Linsley?
- Eric Linsley is Managing General Partner at BioInnovation Capital, where he oversees fund operations, manages the North Carolina laboratory, and invests in therapeutics, laboratory tools, diagnostics, and devices. He previously spent over two decades at Pappas Ventures in Durham, North Carolina, where he sourced and managed investments in numerous life sciences companies, including Peninsula Pharmaceuticals (acquired by Johnson & Johnson), Cerexa (acquired by Forest Laboratories), and public companies such as LipoScience, Liquidia, and Ultragenyx. Prior to Pappas Ventures, he served as Chief Financial Officer of AutoCyte and TriPath Imaging, a medical device company acquired by Becton Dickinson in 2006.
- Where does Eric Linsley work?
- Eric Linsley is Managing Partner at BioInnovation Capital and Board director at Cereius and Executive at Envisia Therapeutics.
- What check size does Eric Linsley write?
- Eric Linsley typically writes checks of $100K – $5M.
- What boards does Eric Linsley sit on?
- Eric Linsley holds tracked board seats at Cereius.
- Where did Eric Linsley go to school?
- Eric Linsley studied at The Wharton School (MBA, Marketing); New York University (Master of Science - MS, Accounting); Trinity College-Hartford (Bachelor of Science - BS, Economics).
Same school
Also attended The Wharton School2,000
+ 1,994 more
Also attended New York University616
+ 610 more
Also attended Trinity College-Hartford86
+ 80 more
Shared employers
Also worked at BioLabs North Carolina1
Also worked at Bain & Company1,094
+ 1,088 more
Also worked at McKinsey & Company2,000
.jpg)
+ 1,994 more